Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 6Brain Neoplasms 3Pain 2Neuralgia 2Glioma 2Depression 2Visceral Pain 1Rectal Neoplasms 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Language Disorders 1Headache 1Glioblastoma 1Fatigue 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1Cancer Survivor 1Anxiety Disorders 1Agnosia 1Acromegaly 1

Interventions

Temozolomide 156Bevacizumab 69Radiotherapy 61Magnetic Resonance Spectroscopy 59Irinotecan 31Surgical Procedures, Operative 23Radiation 23Carboplatin 23Specimen Handling 20Carmustine 20Nivolumab 19Biopsy 17Lomustine 16Aminolevulinic Acid 15Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12pembrolizumab 12Radiosurgery 12Erlotinib Hydrochloride 12fluorodopa F 18 11Topotecan 11Everolimus 11Blood Specimen Collection 11X-Rays 10IL13-PE38 10dabrafenib 9Etoposide 9ribociclib 8poly ICLC 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Glioma × Transcranial Magnetic Stimulation × Clear all
NCT07285525 2025-12-16

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

Beijing Neurosurgical Institute

Phase NA Active not recruiting
43 enrolled
CNS

Glioma

NCT04209023 2022-09-28

The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest

Neurological Associates of West Los Angeles

Phase NA Suspended
10 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡